X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-12-31 | LTC | Ltc Properties Inc | Boitano David M | EVP, CIO | P - Purchase | $34.44 | +10,000 | 25,626 | +64% | +$344,400 | ||||||
| D | 2025-12-30 | CRMD | Cormedix Inc. | Dunton Alan W | Dir | S - Sale+OE | $13.00 | -20,000 | 40,250 | -33% | -$260,000 | |||||
| M | 2025-12-31 | JCTC | Jewett Cameron Trading Co Ltd | Oregon Community Foundation | 10% | S - Sale | $2.27 | -4,006 | 838,534 | 0% | -$9,091 | |||||
| D | 2025-12-31 | CRWV | Coreweave, Inc. | Venturo Brian M | Chief Strategy Officer | S - Sale+OE | $72.57 | -65,940 | 663,919 | -9% | -$4,785,363 | |||||
| D | 2025-12-31 | CRWV | Coreweave, Inc. | McBee Brannin | Chief Development Officer | S - Sale+OE | $72.57 | -57,636 | 307,964 | -16% | -$4,182,723 | |||||
| D | 2025-12-31 | CRWV | Coreweave, Inc. | Intrator Michael N | CEO, Pres, 10% | S - Sale+OE | $72.25 | -161,427 | 5,922,620 | -3% | -$11,662,514 | |||||
2026-01-02 | JANX | Janux Therapeutics, Inc. | Meyer Andrew Hollman | Chief Business Officer | S - Sale | $13.73 | -1,879 | 83,095 | -2% | -$25,799 | ||||||
| D | 2026-01-02 | JANX | Janux Therapeutics, Inc. | Diraimondo Thomas | Chief Scientific Officer | S - Sale+OE | $13.73 | -2,505 | 155,825 | -2% | -$34,394 | |||||
| D | 2026-01-02 | JANX | Janux Therapeutics, Inc. | Campbell David Alan | Pres, CEO | S - Sale+OE | $13.73 | -8,072 | 381,582 | -2% | -$110,829 | |||||
| D | 2026-01-02 | JANX | Janux Therapeutics, Inc. | Winter Charles M. | Chief Technical Officer | S - Sale+OE | $13.73 | -2,401 | 106,321 | -2% | -$32,966 | |||||
| D | 2026-01-02 | JANX | Janux Therapeutics, Inc. | McIver Zachariah | Chief Medical Officer | S - Sale+OE | $13.73 | -2,714 | 52,286 | -5% | -$37,263 | |||||
| D | 2026-01-02 | JANX | Janux Therapeutics, Inc. | Dobek Maria | VP, Accounting | S - Sale+OE | $13.73 | -1,462 | 34,308 | -4% | -$20,073 | |||||
2025-12-30 | SNAP | Snap Inc | Spiegel Evan | CEO, 10% | S - Sale | $8.00 | -1,258,850 | 30,099,361 | -4% | -$10,072,059 | ||||||
| M | 2025-12-30 | AVAH | Aveanna Healthcare Holdings, Inc. | Cunningham Patrick A. | Chief Compliance Officer | S - Sale | $8.12 | -36,015 | 293,354 | -11% | -$292,488 | |||||
| M | 2025-12-30 | AVAH | Aveanna Healthcare Holdings, Inc. | Reisz Edwin C. | Chief Administrative Officer | S - Sale | $8.12 | -50,970 | 1,321,114 | -4% | -$413,942 | |||||
| M | 2025-12-30 | AVAH | Aveanna Healthcare Holdings, Inc. | Shaner Jeff | CEO | S - Sale | $8.12 | -84,960 | 2,394,179 | -3% | -$689,985 | |||||
| M | 2025-12-30 | AVAH | Aveanna Healthcare Holdings, Inc. | Stewart Deborah | SVP, Chief Accounting Officer | S - Sale | $8.12 | -34,616 | 251,676 | -12% | -$281,126 | |||||
| M | 2025-12-30 | AVAH | Aveanna Healthcare Holdings, Inc. | Buckhalter Matthew | CFO | S - Sale | $8.12 | -53,077 | 436,980 | -11% | -$431,054 | |||||
| D | 2026-01-02 | ORKA | Oruka Therapeutics, Inc. | Sandler Laura Lee | COO | S - Sale+OE | $28.52 | -13,000 | 205,084 | -6% | -$370,795 | |||||
| D | 2025-12-30 | AGIO | Agios Pharmaceuticals, Inc. | Burns James William | GC | S - Sale+OE | $27.09 | -2,932 | 31,718 | -8% | -$79,428 | |||||
| D | 2025-12-30 | AGIO | Agios Pharmaceuticals, Inc. | Goff Brian | CEO | S - Sale+OE | $27.09 | -18,703 | 143,103 | -12% | -$506,664 | |||||
| D | 2025-12-30 | AGIO | Agios Pharmaceuticals, Inc. | Gheuens Sarah | Chief Medical Officer | S - Sale+OE | $27.09 | -2,932 | 64,795 | -4% | -$79,428 | |||||
| D | 2025-12-30 | AGIO | Agios Pharmaceuticals, Inc. | Milanova Tsveta | Chief Commercial Officer | S - Sale+OE | $27.09 | -2,932 | 29,190 | -9% | -$79,428 | |||||
| D | 2025-12-30 | AGIO | Agios Pharmaceuticals, Inc. | Jones Cecilia | CFO | S - Sale+OE | $27.09 | -2,932 | 37,394 | -7% | -$79,428 | |||||
2025-12-31 | VENU | Venu Holding Corp | Craddock Matthew | Dir | P - Purchase | $8.15 | +285 | 75,285 | 0% | +$2,321 | ||||||
2025-12-30 | IIF | Morgan Stanley India Investment Fund, Inc. | Saba Capital Management, L.P. | 10% | S - Sale | $24.92 | -18,932 | 988,924 | -2% | -$471,785 | ||||||
| M | 2025-12-30 | GF | New Germany Fund Inc | Saba Capital Management, L.P. | 10% | P - Purchase | $11.38 | +6,587 | 2,210,555 | 0% | +$74,964 | |||||
| D | 2025-12-31 | AXSM | Axsome Therapeutics, Inc. | Saad Mark E | Dir | S - Sale+OE | $165.18 | -37,577 | 10,302 | -78% | -$6,206,969 | |||||
2025-12-31 | MEGI | Nyli Cbre Global Infrastructure Megatrends Term Fund | Saba Capital Management, L.P. | 10% | S - Sale | $13.83 | -12,500 | 5,593,758 | 0% | -$172,875 | ||||||
| M | 2025-12-30 | WRB | Berkley W R Corp | Mitsui Sumitomo Insurance Co Ltd | 10% | P - Purchase | $70.11 | +672,734 | 50,764,245 | +1% | +$47,167,124 | |||||
| M | 2025-12-30 | ASA | Asa Gold & Precious Metals Ltd | Saba Capital Management, L.P. | 10% | P - Purchase | $60.14 | +16,004 | 5,391,713 | 0% | +$962,492 | |||||
| D | 2026-01-02 | XENE | Xenon Pharmaceuticals Inc. | Mortimer Ian | Pres, CEO | S - Sale+OE | $44.43 | -40,000 | 20,300 | -66% | -$1,777,093 | |||||
2026-01-02 | ZS | Zscaler, Inc. | Beer James A | Dir | S - Sale | $226.72 | -653 | 3,485 | -16% | -$148,048 | ||||||
2025-12-31 | AI | C3.Ai, Inc. | Ehikian Stephen Bradley | CEO | S - Sale | $13.56 | -234,918 | 924,074 | -20% | -$3,185,488 | ||||||
2025-12-31 | ARQT | Arcutis Biotherapeutics, Inc. | Burnett Patrick | See Remarks | S - Sale | $29.20 | -1,697 | 96,610 | -2% | -$49,560 | ||||||
2026-01-02 | MAX | Mediaalpha, Inc. | Yeh Kuanling Amy | CTO | S - Sale | $12.95 | -3,000 | 396,662 | -1% | -$38,850 | ||||||
| D | 2026-01-02 | CYTK | Cytokinetics Inc | Callos Andrew | EVP, Chief Commercial Officer | S - Sale+OE | $62.62 | -1,798 | 50,440 | -3% | -$112,585 | |||||
2026-01-02 | BUKS | Butler National Corp | Daly Joseph Patrick | Dir, 10% | P - Purchase | $3.04 | +2,678 | 8,855,000 | 0% | +$8,141 | ||||||
2026-01-02 | OMF | Onemain Holdings, Inc. | Shulman Douglas H. | Pres, CEO | S - Sale | $68.41 | -57,500 | 174,100 | -25% | -$3,933,790 | ||||||
2025-12-26 | GRX.E | Gabelli Healthcare & Wellnessrx Trust | Gabelli Mario J | Control Person of Adviser, 10% | P - Purchase | $10.00 | +1,800,000 | 2,000,000 | +900% | +$18,000,000 | ||||||
| M | 2025-12-30 | HOWL | Werewolf Therapeutics, Inc. | Evnin Luke | Dir | S - Sale | $0.62 | -78,377 | 2,472,297 | -3% | -$48,431 | |||||
| M | 2025-12-31 | CLNN | Clene Inc. | Ugwumba Chidozie | 10% | S - Sale | $5.79 | -17,110 | 766,480 | -2% | -$99,088 | |||||
2025-12-31 | VRDN | Viridian Therapeutics, Inc.De | Tousignant Jennifer | GC | S - Sale | $31.16 | -2,272 | 0 | -100% | -$70,796 | ||||||
2025-12-31 | BXMT | Blackstone Mortgage Trust, Inc. | Pena Fernando Austin | Pres | S - Sale | $19.24 | -3,131 | 78,633 | -4% | -$60,234 | ||||||
2025-12-30 | PTCT | Ptc Therapeutics, Inc. | Klein Matthew B. | CEO | S - Sale | $76.64 | -8,089 | 341,875 | -2% | -$619,941 | ||||||
2023-02-17 | ALMU | Aeluma, Inc. | McCarthy Lee | 10% | S - Sale | $0.01 | -649,570 | 977,425 | -40% | -$3,962 | ||||||
2025-12-30 | UA | Under Armour, Inc. | Watsa V Prem Et Al | 10% | P - Purchase | $5.12 | +13,182,469 | 51,416,278 | +34% | +$67,443,913 | ||||||
2025-12-30 | SLRX | Salarius Pharmaceuticals, Inc. | Hanish Arnold C | Dir | S - Sale | $0.64 | -27 | 5,000 | -1% | -$17 | ||||||
2025-12-30 | BETR | Better Home & Finance Holding Co | Menon Bhaskar | Dir | P - Purchase | $33.94 | +1,500 | 1,500 | New | +$50,910 | ||||||
| DM | 2025-12-30 | UWMC | Uwm Holdings Corp | Mat Ishbia | Pres, CEO, 10% | S - Sale+OE | $4.41 | -1,898,622 | 6,594,112 | -22% | -$8,366,594 | |||||
2025-12-31 | FGBI | First Guaranty Bancshares, Inc. | Smith Edgar R. III | Dir | P - Purchase | $5.40 | +208,996 | 5,191,301 | +4% | +$1,128,578 | ||||||
2025-12-31 | FGBI | First Guaranty Bancshares, Inc. | Reynolds Marshall T | Dir | P - Purchase | $5.40 | +46,297 | 2,109,968 | +2% | +$250,004 | ||||||
2025-12-30 | RNXT | Renovorx, Inc. | Agah Ramtin | Chief Medical Officer | P - Purchase | $0.83 | +205 | 778,665 | 0% | +$169 | ||||||
2025-12-30 | MCAGU | Mountain Crest Acquisition Corp. V | Liu Suying | CEO, CFO, 10% | S - Sale | $5.00 | -200,000 | 1,865,800 | -10% | -$1,000,000 | ||||||
| M | 2025-12-30 | RH | Rh | Demilio Mark S | Dir | S - Sale | $182.30 | -900 | 55,858 | -2% | -$164,068 | |||||
2025-12-31 | AUUD | Auddia Inc. | Thramann Jeffrey John | CEO, Exec COB | S - Sale | $0.96 | -2,301 | 2,356 | -49% | -$2,197 | ||||||
2025-12-30 | MCAGU | Mountain Crest Acquisition Corp. V | Mountain Crest Global Holdings LLC | 10% | S - Sale | $5.00 | -200,000 | 1,865,800 | -10% | -$1,000,000 | ||||||
2026-01-02 | CPNG | Coupang, Inc. | Lee Jonathan D. | Chief Accounting Officer | S - Sale | $23.62 | -2,679 | 122,096 | -2% | -$63,278 | ||||||
| D | 2026-01-02 | CURI | Curiositystream Inc. | Hayden Phillip Brady | CFO | S - Sale+OE | $3.76 | -17,474 | 126,667 | -12% | -$65,662 | |||||
2025-12-31 | JOBY | Joby Aviation, Inc. | Thompson Michael N. Jr. | Dir | P - Purchase | $13.24 | +1,100 | 18,685,118 | 0% | +$14,564 | ||||||
2025-12-30 | JOBY | Joby Aviation, Inc. | Allison Eric | Chief Product Officer | S - Sale | $13.25 | -32,448 | 659,980 | -5% | -$429,936 | ||||||
2026-01-02 | PATH | Uipath, Inc. | Dines Daniel | CEO, COB, 10% | S - Sale | $16.38 | -45,000 | 38,048,882 | 0% | -$737,307 | ||||||
2026-01-02 | CNO | Cno Financial Group, Inc. | Bhojwani Gary C. | CEO | S - Sale | $41.99 | -31,430 | 831,397 | -4% | -$1,319,639 | ||||||
2026-01-02 | ALKS | Alkermes Plc. | Hopkinson Craig C. | EVP R, D, Chief Medical Office | S - Sale | $28.00 | -4,000 | 61,740 | -6% | -$112,000 | ||||||
2025-12-31 | CGC | Canopy Growth Corp | Yanofsky Theresa | Dir | S - Sale | $1.13 | -10,434 | 63,518 | -14% | -$11,790 | ||||||
2025-12-31 | INTU | Intuit Inc. | Cook Scott D | Dir | S - Sale | $668.02 | -1,402 | 5,668,182 | 0% | -$936,564 | ||||||
2025-12-31 | CGC | Canopy Growth Corp | Lazzarato David Angelo | Dir | S - Sale | $1.13 | -15,715 | 87,672 | -15% | -$17,758 | ||||||
| D | 2026-01-02 | UTHR | United Therapeutics Corp | Mahon Paul A | EVP, GC | S - Sale+OE | $485.43 | -8,300 | 36,781 | -18% | -$4,029,076 | |||||
2025-12-30 | ANNX | Annexon, Inc. | Carson William H. | Dir | P - Purchase | $5.02 | +4,115 | 54,405 | +8% | +$20,657 | ||||||
2025-12-31 | TRAK | Repositrak, Inc. | Fields Randall K | CEO, 10% | S - Sale | $12.34 | -7,500 | 4,858,107 | 0% | -$92,587 | ||||||
2025-12-31 | ALSN | Allison Transmission Holdings Inc | Coll John | SVP, Global MSS | S - Sale | $98.79 | -1,791 | 18,927 | -9% | -$176,933 | ||||||
| M | 2025-02-28 | CMTV | Community Bancorp /Vt | Laforce David | Dir | P - Purchase | $20.63 | +207 | 8,824 | +2% | +$4,269 | |||||
2026-01-02 | FG | F&G Annuities & Life, Inc. | Blunt Christopher O | CEO | P - Purchase | $29.56 | +5,000 | 1,117,396 | 0% | +$147,800 | ||||||
2025-12-30 | ONTF | On24 Inc. | Vattuone Steven | CFO | S - Sale | $7.98 | -80,000 | 452,654 | -15% | -$638,744 | ||||||
2025-12-30 | ONTF | On24 Inc. | Sahasi Jayesh | EV Pres, Product, CTO | S - Sale | $7.98 | -34,753 | 672,527 | -5% | -$277,433 | ||||||
| D | 2025-12-30 | ONTF | On24 Inc. | Blackie James | Chief Revenue Officer | S - Sale+OE | $7.96 | -16,000 | 478,861 | -3% | -$127,360 | |||||
2025-12-31 | PCVX | Vaxcyte, Inc. | Dhaliwal Harpreet S. | Chief Technical Ops Officer | S - Sale | $46.69 | -9,743 | 23,928 | -29% | -$454,891 | ||||||
| M | 2025-12-29 | LUCY | Innovative Eyewear Inc | Galkin Vladimir | 10% | P - Purchase | $1.03 | +148,502 | 647,505 | +30% | +$153,081 | |||||
2026-01-02 | YELP | Yelp Inc | Saldanha Craig | Chief Product Officer | S - Sale | $30.43 | -1,200 | 192,079 | -1% | -$36,516 | ||||||
| D | 2025-12-30 | NUVL | Nuvalent, Inc. | Noci Darlene | Chief Development Officer | S - Sale+OE | $100.05 | -4,000 | 48,034 | -8% | -$400,179 | |||||
2025-12-31 | RCUS | Arcus Biosciences, Inc. | Goeltz II Robert C. | CFO | S - Sale | $23.38 | -6,552 | 67,924 | -9% | -$153,186 | ||||||
2025-12-31 | ACT | Enact Holdings, Inc. | Genworth Holdings, Inc. | 10% | S - Sale | $39.47 | -908,673 | 115,223,783 | -1% | -$35,863,960 | ||||||
| D | 2025-12-31 | ZLAB | Zai Lab Ltd | Amado Rafael | See Remarks | S - Sale+OE | $17.43 | -10,787 | 52,391 | -17% | -$188,039 | |||||
2025-12-30 | EU | Encore Energy Corp. | Sheriff William M | See Remarks | S - Sale | $2.42 | -16,500 | 2,293,431 | -1% | -$39,930 | ||||||
2026-01-02 | AKAM | Akamai Technologies Inc | Karon Adam | COO, GM Edge Technology Group | S - Sale | $87.30 | -3,320 | 7,886 | -30% | -$289,836 | ||||||
2025-12-31 | SAIC | Science Applications International Corp | Attili Srinivas | EVP, Civilian | P - Purchase | $101.26 | +100 | 13,635 | +1% | +$10,126 | ||||||
2025-12-31 | FGBI | First Guaranty Bancshares, Inc. | McAnally Bruce | Dir | P - Purchase | $5.40 | +92,600 | 331,087 | +39% | +$500,040 | ||||||
| M | 2025-12-30 | SUNS | Sunrise Realty Trust, Inc. | Tannenbaum Leonard M | Exec COB, 10% | P - Purchase | $9.50 | +137,000 | 3,704,997 | +4% | +$1,301,490 | |||||
2025-12-31 | COCP | Cocrystal Pharma, Inc. | Frost Phillip Md Et Al | Dir, 10% | P - Purchase | $0.95 | +50,000 | 1,865,651 | +3% | +$47,275 | ||||||
| DM | 2025-12-30 | MNTR | Mentor Capital, Inc. | Billingsley Chester | CEO, 10% | P - Purchase | $0.08 | +2,000 | 3,156,296 | 0% | +$168 | |||||
2025-12-30 | HQI | Hirequest, Inc. | Hermanns Richard | Pres, CEO, 10% | P - Purchase | $10.28 | +9,704 | 2,951,283 | 0% | +$99,757 | ||||||
2025-12-31 | LSAK | Lesaka Technologies Inc | Mazanderani Ali | Exec COB | P - Purchase | $5.00 | +1,800,000 | 2,325,115 | +343% | +$9,000,000 | ||||||
2025-12-31 | PHIO | Phio Pharmaceuticals Corp. | Bitterman Robert J | COB, Pres, CEO | P - Purchase | $1.03 | +5,000 | 291,421 | +2% | +$5,150 | ||||||
| D | 2025-12-30 | FBRX | Forte Biosciences, Inc. | Riley Antony A | CFO | P - Purchase | $26.33 | +9,680 | 41,741 | +30% | +$254,833 | |||||
2025-12-31 | LOCL | Local Bounti Corporation/De | Nordby Matthew | Dir | S - Sale | $2.14 | -1,000 | 101,705 | -1% | -$2,137 | ||||||
| D | 2025-12-30 | LULU | Lululemon Athletica Inc. | Frank Meghan | CFO | S - Sale+OE | $211.37 | -2,658 | 25,626 | -9% | -$561,821 | |||||
2025-12-30 | CUE | Cue Biopharma, Inc. | Sarraf Pasha | Dir | P - Purchase | $0.31 | +323,857 | 323,857 | New | +$99,747 | ||||||
2025-12-31 | MPB | Mid Penn Bancorp Inc | Abel Robert A | Dir | P - Purchase | $31.02 | +16 | 36,717 | 0% | +$496 | ||||||
2025-12-31 | MPB | Mid Penn Bancorp Inc | Brumbaugh Kimberly J | Dir | P - Purchase | $31.02 | +80 | 13,486 | +1% | +$2,482 | ||||||
2025-12-31 | MPB | Mid Penn Bancorp Inc | De Soto Matthew G | Dir | P - Purchase | $31.02 | +257 | 118,499 | 0% | +$7,972 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |